Literature DB >> 11532277

Deposition of C3b/iC3b leads to the concealment of antigens, immunoglobulins and bound C1q in complement-activating immune complexes.

U R Nilsson1.   

Abstract

Complement activation by bound IgG in serum at physiological concentrations is reflected in the deposition of C3b/iC3b in the absence of antigenic expression of the IgG or of any bound C1q on the target. The aim of this study was to investigate the functional requirements for this phenomenon and to establish its relationship to a release or concealment of the antigens. Microtiter wells coated with IgG by direct adsorption or by binding of IgG antibodies to pre-adsorbed homologous antigen were incubated with serum or serum reagents at 37 degrees C. The complement reaction was analyzed by ELISA to quantitate bound or released reaction products, and the release of IgG from the coated microtiter wells was gauged radiometrically. In the presence of serum, rapid binding of C1q and C3b occurred and was soon followed by a rapid loss of C1q expression; C3b binding remained high. Loss of IgG paralleled that of C1q. The functional requirement for the reaction was restricted to the activation and deposition of C3b/iC3b but was dependent of the combined function of the classical and alternative complement pathways. The loss of the IgG antigen was solely the result of antigen concealment, whereas the loss of C1q was only partly so. In biological terms, the concealment of bound IgG and C1q may reflect mechanisms by which complement down-regulates leukocyte responses stimulated by ligand-cell membrane receptor interactions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532277     DOI: 10.1016/s0161-5890(01)00039-6

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  7 in total

1.  Fetal bovine serum xenoproteins modulate human monocyte adhesion and protein release on biomaterials in vitro.

Authors:  David Schmidt; Evan James Joyce; Weiyuan John Kao
Journal:  Acta Biomater       Date:  2010-09-15       Impact factor: 8.947

Review 2.  Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis.

Authors:  Robert A DeAngelis; Edimara S Reis; Daniel Ricklin; John D Lambris
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

3.  Inhibition of biomaterial-induced complement activation attenuates the inflammatory host response to implantation.

Authors:  Ioannis Kourtzelis; Stavros Rafail; Robert A DeAngelis; Periklis G Foukas; Daniel Ricklin; John D Lambris
Journal:  FASEB J       Date:  2013-04-04       Impact factor: 5.191

4.  Two conformational forms of target-bound iC3b that distinctively bind complement receptors 1 and 2 and two specific monoclonal antibodies.

Authors:  Ulf R Nilsson; Lillemor Funke; Bo Nilsson; Kristina N Ekdahl
Journal:  Ups J Med Sci       Date:  2010-11-11       Impact factor: 2.384

5.  Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.

Authors:  Linda Mathsson; Jon Lampa; Mohammed Mullazehi; Johan Rönnelid
Journal:  Arthritis Res Ther       Date:  2006-03-28       Impact factor: 5.156

6.  The Alternative Pathway Is Necessary and Sufficient for Complement Activation by Anti-THSD7A Autoantibodies, Which Are Predominantly IgG4 in Membranous Nephropathy.

Authors:  Pallavi Manral; Tiffany N Caza; Aaron J Storey; Laurence H Beck; Dorin-Bogdan Borza
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

7.  Assessment of the Role of C3(H2O) in the Alternative Pathway.

Authors:  Karin Fromell; Anna Adler; Amanda Åman; Vivek Anand Manivel; Shan Huang; Claudia Dührkop; Kerstin Sandholm; Kristina N Ekdahl; Bo Nilsson
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.